ArticleFrontiers in microbiology2025
Prognostic factors of invasive fungal infections in pediatric intensive care units and changes in treatment outcomes before and after the COVID-19 pandemic: a multicenter retrospective study.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the prognostic factors influencing the outcomes of children with invasive fungal infection in pediatric intensive care unit (PICU) and explore the effects of changes in clinical characteristics before and after the COVID-19 pandemic on treatment outcomes. Methods: In total, 665 children with invasive fungal infections from the PICUs of four hospitals in China were retrospectively enrolled from January 2017 to December 2021. These children were categorized into an effective treatment group (336 cases) and a failure group (329 cases, including treatment abandonment and death) based on prognosis. Clinical data were compared between the pre-pandemic period (2017-2019, 421 cases) and the post-pandemic period (2020-2021, 244 cases). Univariate and multivariate logistic regression analyses were used to identify the factors related to prognosis. Results: Prognostic factors: Independent risk factors for treatment failure included agranulocytosis (OR = 3.389, 95% CI 1.518-6.287), hematological malignancies (OR = 3.050, 95% CI 1.544-5.986), blood transfusion (OR = 2.239, 95% CI 1.456-3.442), invasive mechanical ventilation (OR = 1.938, 95% CI 1.158-3.243), and indwelling urinary catheter (OR = 1.750, 95% CI 1.048-2.924). The independent protective factor was identified fungal pathogens (OR = 0.588, 95% CI 0.362-0.956). Pre- and post-pandemic comparisons revealed that the co-infection rate decreased after pandemic (77.9% vs. 70.5%, Conclusion: Agranulocytosis, hematologic malignancies, invasive mechanical ventilation, indwelling urinary catheter and blood transfusion are independent risk factors for adverse outcomes with invasive fungal infections in PICU, and identifying the pathogen can improve outcomes. Post-pandemic changes in fungal species and cumulative risk factors may have offset the potential benefits of reduced co-infection rates, leading to increased treatment failure rates. Therefore, it is necessary to optimize invasive procedure management and provide early coverage for emerging pathogens in high-risk children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.